Carbohydrate sulfotransferases: Novel therapeutic targets for inflammation, viral infection and cancer

Drug Discovery Today

Volumn 6, Issue 1, 2001, Pages 27-35

  Hemmerich, Stefan ^a,b  

^a ROCHE BIOSCIENCE   (United States)

^b Thios Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BIMOSIAMOSE; CARBOHYDRATE; HEPARIN; L SELECTIN; SULFOTRANSFERASE; SULFOTRANSFERASE INHIBITOR;

CANCER; CRYSTALLOGRAPHY; DRUG STRUCTURE; HUMAN; INFLAMMATION; LYMPHOCYTE MIGRATION; NONHUMAN; REVIEW; SULFATION; VIRUS INFECTION;

EID: 0035137043     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01581-6     Document Type: Review

References (77)

1. Cell adhesion: a new target for therapy
2. Adhesion molecules-Part I
3. Adhesion molecules-Part II: Blood vessels and blood cells
4. Blocking of adhesion molecules in vivo as anti-inflammatory therapy
5. Intercellular adhesion in vascular biology, thrombosis and cancer
6. Platelet adhesion receptors: novel targets for anti-thrombotic therapy
7. Anti-adhesion cancer therapy
8. Development of eptifibatide
9. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents
10. Sulfonopeptide inhibitors of leukocyte adhesion
11. Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains
12. Regulation of L-selectin-mediated rolling through receptor dimerization
13. Dimerization of P-selectin glycoprotein ligand-1 (PSGL-1) required for optimal recognition of P-selectin
14. Isolation and characterization of natural protein-associated carbohydrate ligands for E-selectin
15. Synthesis of a divalent sialyl Lewis X O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin
16. Strength in numbers: non-natural polyvalent carbohydrate derivatives
17. Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyses tyrosine O-sulfation, a common post-translational modification of eukaryotic proteins
18. Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans
19. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding
20. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
21. Carbohydrate sulfotransferases: mediators of extracellular communication
22. Leukocyte adhesion: two selectins converge on sulfate
23. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase
24. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry
25. Carbohydrate Sulfotransferases
26. Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci
27. Carbohydrate sulfotransferases in lymphocyte homing
28. Targeting of proteins to the Golgi apparatus
29. Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase
30. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1
31. Enzymology of human cytosolic sulfotransferases
32. Sulfation in high endothelial venules: cloning and expression of the human PAPS synthetase
33. Chlorate-a potent inhibitor of protein sulfation in intact cells
34. The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis
35. How do kinases transfer phosphoryl groups?
36. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase
37. Heparan sulfate proteoglycans of the cardiovascular system; specific structures emerge but how is synthesis regulated?
38. The purification and mechanism of action of human antithrombin-heparin cofactor
39. Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool
40. Heparin structure and interactions with basic fibroblast growth factor
41. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration
42. Lymphocyte homing and homeostasis
43. A tissue-specific endothelial cell molecule involved in lymphocyte homing
44. The human peripheral lymph node vascular addressin
45. Endothelial L-selectin ligands are likely to recruit lymphocytes into human rejecting heart transplants
46. L-selectin ligands in bronchial asthma but not in other chronic inflammatory lung diseases
47. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice
48. 7 integrin homing receptor pathways mediate peripheral lymphocyte traffic to AKR mouse hyperplastic thymus
49. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor
50. Further characterization of the interaction between L-selectin and its endothelial ligands
51. Sulfation-dependent recognition of HEV-ligands by L-selectin and MECA-79, an adhesion-blocking mAb
52. An endothelial ligand for L-selectin is a novel mucin-like molecule
53. 6′-sulfated sialyl Lewis X is a major capping group of GlyCAM-1
54. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin
55. Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X
56. Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin
57. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl lewis X, an L-selectin ligand displayed by CD34
58. Cloning and characterization of a mammalian N-acetylglucosamine-6-sulfotransferase that is highly restricted to intestinal tissue
59. Cell adhesion molecules: selectins and integrins
60. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites
61. Humoral immune responses in L-selectin-deficient mice
62. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase
63. The structure-based design of ATP-site directed protein kinase inhibitors
64. Common food additives are potent inhibitors of human liver 17 alpha-ethinyloestradiol and dopamine sulfotransferases
65. Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase
66. Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity?
67. Discovery of carbohydrate sulfotransferase inhibitors from a kinase-directed library
68. Differential carbohydrate recognition of two GlcNAc-6-sulfotransferases with possible roles in L-selectin ligand biosynthesis
69. Identification of an N-acetylglucosamine-6-O-sulfotransferase activity specific to lymphoid tissue: an enzyme with a possible role in lymphocyte homing
70. A continuous assay for the spectrophotometric analysis of sulfotransferases using aryl sulfotransferase IV
71. High-level expression and purification of a recombinant human alpha-1,3-fucosyltransferase in baculovirus-infected insect cells
72. Affinity and kinetic analysis of L-selectin (CD62L) binding to GlyCAM-1
73. Selectins
74. Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)phenyl]hexane (TBC1269)